Pseudane V alleviates ox-LDL-induced macrophage M1 polarization by inhibiting m6A modification of PPARGC1A

Tao Li1, Qi Pang2, Jun Pan3

  • 1Department of Cardiology, Lanzhou Petrochemical General Hospital (The Fourth Affiliated Hospital of Gansu University of Chinese Medicine), Lanzhou, 730060, China.

Experimental Cell Research
|November 26, 2025
PubMed

Insights

Oxidized LDL triggers N6-methyladenosine (m6A) RNA changes, promoting M1 macrophage polarization and atherosclerosis. Marine natural product Pseudane V reverses these m6A modifications, offering potential atherosclerosis prevention.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cardiovascular Research

Background:

  • Atherosclerosis pathogenesis involves macrophage dysfunction driven by oxidized low-density lipoprotein (ox-LDL).
  • The precise molecular mechanisms, including RNA methylation, governing ox-LDL-induced macrophage polarization are not fully understood.
  • Targeting macrophage polarization presents a therapeutic strategy for atherosclerosis.

Purpose of the Study:

  • To elucidate the role of N6-methyladenosine (m6A) RNA methylation in ox-LDL-induced M1 macrophage polarization.
  • To identify downstream targets of the ox-LDL-m6A pathway in macrophages.
  • To discover marine natural products capable of reversing ox-LDL-driven macrophage polarization for atherosclerosis intervention.

Main Methods:

  • Human monocytic THP-1 cells were differentiated and treated with ox-LDL.
  • Macrophage polarization (M1/M2) was assessed via flow cytometry and qRT-PCR.
  • Global m6A levels were analyzed using dot blot; MeRIP-seq and RNA-seq identified target genes.
  • High-throughput screening of marine natural products was performed.

Main Results:

  • Ox-LDL induced M1 macrophage polarization, associated with increased global RNA m6A modification.
  • Ox-LDL-induced m6A suppressed PPARGC1A expression in a YTHDF2-dependent manner, promoting M1 polarization.
  • Marine natural product Pseudane V reversed ox-LDL-induced M1 polarization and protected endothelial cells by normalizing PPARGC1A m6A modification.

Conclusions:

  • Ox-LDL promotes atherosclerosis by increasing m6A modification of PPARGC1A, suppressing its expression and driving M1 macrophage polarization.
  • Pseudane V effectively counteracts ox-LDL-induced m6A changes, inhibiting M1 polarization.
  • Pseudane V demonstrates potential as a therapeutic agent for preventing atherosclerosis.